Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Further Reading

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

From TetraScience, Inc. 12 Jan 2022
AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

11 Jan 2022
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics

NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics

From PhoreMost 11 Jan 2022
Providing recombinant antibody services and more within Europe

Providing recombinant antibody services and more within Europe

From Sino Biological Inc. 11 Jan 2022
Therapeutic in vivo synthetic chemistry used to make anticancer drugs

Therapeutic in vivo synthetic chemistry used to make anticancer drugs

10 Jan 2022
Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

9 Jan 2022
Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

6 Jan 2022
Research may pave the way for designing new therapies to combat schistosomiasis

Research may pave the way for designing new therapies to combat schistosomiasis

6 Jan 2022
PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

From PhoreMost 6 Jan 2022
Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

5 Jan 2022
Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

4 Jan 2022
Sino Biological Establishes New Location in Houston, Texas

Sino Biological Establishes New Location in Houston, Texas

From Sino Biological Inc. 4 Jan 2022
New technique combines bioprinting with cryopreservation to construct frozen structures

New technique combines bioprinting with cryopreservation to construct frozen structures

31 Dec 2021
Scientists identify a new Achilles' heel of influenza virus

Scientists identify a new Achilles' heel of influenza virus

24 Dec 2021
New study shines light on how brain cells die in prion diseases

New study shines light on how brain cells die in prion diseases

22 Dec 2021
Study points toward an alternative drug strategy to stall Alzheimer’s neurodegeneration

Study points toward an alternative drug strategy to stall Alzheimer’s neurodegeneration

22 Dec 2021
Identifying protein targets in SARS-CoV-2 via machine learning

Identifying protein targets in SARS-CoV-2 via machine learning

17 Dec 2021
Engineering of brain-mimetic injectable hydrogel scaffolds with self-healing properties

Engineering of brain-mimetic injectable hydrogel scaffolds with self-healing properties

15 Dec 2021
Rare population of toxic senescent cells in the brain could be a target for Alzheimer's treatment

Rare population of toxic senescent cells in the brain could be a target for Alzheimer's treatment

11 Dec 2021
Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

From Optibrium Ltd. 9 Dec 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback